Arrowhead Pharmaceuticals Inc Cash Flow Reinvestment Rate
Arrowhead Pharmaceuticals Inc cash flow reinvestment rate. Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Reinvestment Rate of 4.27x as of September 2025, reinvesting $87.60 Million (capex $7.49 Million plus investments $80.11 Million) from operating cash flow of $20.49 Million. Explore how well can Arrowhead Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Arrowhead Pharmaceuticals Inc (1997–2025)
Cash flow reinvestment rate of Arrowhead Pharmaceuticals Inc from 1997 to 2025. Historical reinvestment intensity for Arrowhead Pharmaceuticals Inc across 4 annual periods. Explore Arrowhead Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Arrowhead Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (1997–2025)
Arrowhead Pharmaceuticals Inc cash flow reinvestment rate by year from 1997 to 2025. Year-by-year capital reinvestment analysis for Arrowhead Pharmaceuticals Inc. For the full cash flow conversion analysis, see ARWR cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | $151.96 Million | $179.55 Million | $22.67 Million | ▲ +2.3% |
| 2021 | 0.83x | $141.68 Million | $171.22 Million | $23.57 Million | ▲ +139.6% |
| 2019 | 0.35x | $59.75 Million | $173.03 Million | $12.00 Million | — |
| 1997 | 0.00x | $0.00 | $4.56K | $0.00 | — |